REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/20/2026
Back to search
Official data from USPTO
ENZYVANT CONNECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ENZYVANT CONNECT
ST13
US500000088959741Class
35, 41, 44, 45
Filing
88959741
Registration
6423166
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
07/20/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 41, 44, 45
Filing date
06/11/2020
Registration date
07/20/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/20/2021
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Basel, CH
Examiner
MCDORMAN, ROGER THOMAS
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Enzyvant Therapeutics GmbH
Representatives
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 35Class 41Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Healthcare operations management services; healthcare operations management servicesconnecting patients to healthcare resources in the nature of connecting consumers with qualified service providers
Class 41
Educational servicesorganizing and conducting classesseminarsconferencessymposiums and workshops in the health and medical field; educational servicesorganizing and conducting classesseminarsconferencessymposiums and workshops in the field of pharmaceuticalbiomedical and biological therapeutic research; educational servicesorganizing and conducting classesseminarsconferencessymposiums and workshops for patients and their families and caregivers regarding the diagnosistreatment and care of rare diseases and disorders and immunological diseases and disorders
Class 44
Providing health information and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions; providing information to patients and their families and caregivers relating to the diagnosistreatment and care of patients with rare diseases and disorders and immunological diseases and disorders
Class 45
Patient advocacy servicesproviding care coordination services to patients and their families and caregivers in the nature of researching and case managementcoordination of care among providers and facilitiesmedication managementdisease managementhealthcare educationpatient advocacycompliance with the patient's plan of care; non-therapeutic counseling rendered to meet the needs of individuals; providing emotional support for patients and their families via interactive on-line forums; providing companionship services for families of patients with threatening disorders
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/26/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2021
ALIE
ASSIGNED TO LIE
03/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/21/2020
GNRT
NON-FINAL ACTION E-MAILED
09/21/2020
CNRT
NON-FINAL ACTION WRITTEN
09/21/2020
DOCK
ASSIGNED TO EXAMINER
09/15/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/08/2020
ALIE
ASSIGNED TO LIE
08/06/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2020
NWAP
NEW APPLICATION ENTERED
06/15/2020
Continuous trademark protection
Get notified about every new filing that threatens ENZYVANT CONNECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.